Cite
Yao Y, Ma D, Xu Y, et al. Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells. Exp Eye Res. 2021;214:108864doi: 10.1016/j.exer.2021.108864.
Yao, Y., Ma, D., Xu, Y., Yuan, X. L., Liang, J. J., Chen, S. L., Jhanji, V., & Ng, T. K. (2021). Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells. Experimental eye research, 214108864. https://doi.org/10.1016/j.exer.2021.108864
Yao, Yao, et al. "Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells." Experimental eye research vol. 214 (2021): 108864. doi: https://doi.org/10.1016/j.exer.2021.108864
Yao Y, Ma D, Xu Y, Yuan XL, Liang JJ, Chen SL, Jhanji V, Ng TK. Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells. Exp Eye Res. 2021 Nov 24;214:108864. doi: 10.1016/j.exer.2021.108864. Epub 2021 Nov 24. PMID: 34826419; PMCID: PMC8610570.
Copy
Download .nbib